A narrow 10–7 vote ended GLP-1 coverage for state employees, citing high premium costs and a tight state budget.

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

Appetite is governed by gut hormones, not willpower. GLP-1 therapies extend natural satiety signals and expose the biology ...

An investigational GLP-1 receptor agonist pill edged out oral semaglutide (Rybelsus) for improving blood glucose in adults with type 2 diabetes inadequately controlled on metformin, the phase III ...

Eli Lilly has spent months signaling it would challenge Novo Nordisk’s oral GLP-1 franchise. Now it has data to back that up.

Ozempic and similar weight-loss medications are hailed as miracle drugs. But there are plenty of unknowns about long-term use ...

Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.

Britain's medicines regulator said on Wednesday it raided two premises in Lincolnshire and Nottinghamshire, seizing almost 2,000 doses of illegal weight-loss drugs and manufacturing equipment in its ...